Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by JohnDDon Sep 18, 2014 7:24pm
379 Views
Post# 22950171

RE:Time to get the wife working. Need2 get cash in.

RE:Time to get the wife working. Need2 get cash in.Need2, Great to have you and your humour back. as.we need2 have a good dose of humuor with this company...

Updated presentation today and I noticed the following statement which is something new for me...they are considering selling the Pennsaid franchise...

"U.S. rights to lead commercial product (Pennsaid® 2%) reacquired and in process of being relicensed or sold"

"Relicense/sell U.S. rights to Pennsaid franchise – Q4 2014/Q1 2015"
Maybe I missed it in the past, but this is the first time I have seen them seriously talk about selling the Pennsaid franchise..If you believe they could license Pennsaid and P2 in the U.S. for ~$25 million how much would an outright sale of the entire franchise be worth? I would think a lot more than $25 million..

I will hazard to bet that there is a greater than 50% chance they sell the entire Pennsaid franschise lock stock and barrel by year end. That would be such great news...Maybe John and Dan are growing tired of the business and have an eye for retirement....




 


 
Bullboard Posts